The C-X-C chemokine receptor type 4 (CXCR4) is downregulated on CML cells, while its expression is upregulated in the presence of imatinib, increasing migration towards stroma and inducing G0-G1 cell cycle arrest77. This evidence concerns the gene CXCR4 and chronic myelogenous leukemia, BCR-ABL1 positive.